Drug application
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE, IBUPROFEN)
Drugs@FDA ANDA 204575 · AUROLIFE PHARMA LLC
Key facts
| Drug name | HYDROCODONE BITARTRATE AND IBUPROFEN |
|---|---|
| Active ingredients | HYDROCODONE BITARTRATE, IBUPROFEN |
| Application type | ANDA |
| Application number | 204575 |
| Company | AUROLIFE PHARMA LLC |
| Dosage forms | TABLET, ORAL |
| Strength | 7.5MG;200MG |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Jun 2, 2016 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: